Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor

Biochemistry

Volumn 47, Issue 16, 2008, Pages 4826-4833

  Cohen, Tomer ^a   Pevsner Fischer, Meirav ^a   Cohen, Noam ^a   Cohen, Irun R ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; COMPUTER SIMULATION; GLYCOPROTEINS; MOLECULAR DYNAMICS; SYNTHESIS (CHEMICAL); VIRUSES;

HELICAL TRANSMEMBRANE DOMAINS; HYDROPHOBIC CORES;

PEPTIDES;

CYTOKINE; GLYCOPROTEIN GP 41; MUTANT PROTEIN; PHENYLALANINE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; VIRUS PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CYTOKINE RELEASE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRION; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIGENS, CD3; CELL MEMBRANE; CELL PROLIFERATION; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP41; HIV-1; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; T-LYMPHOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 42349109423     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800100p     Document Type: Article

References (56)

1. Freed, E. O., Myers, D. J., and Risser, R. (1990) Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc. Natl. Acad. Sci. U.S.A. 87, 4650-4654.
2. Frey, S., and Tamm, L. K. (1990) Membrane insertion and lateral diffusion of fluorescence-labelled cytochrome c oxidase subunit IV signal peptide in charged and uncharged phospholipid bilayers. Biochem. J. 272, 713-719.
3. Gordon, L. M., Curtain, C. C., Zhong, Y. C., Kirkpatrick, A., Mobley, P. W., and Waring, A. J. (1992) The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: Peptide conformation, orientation and aggregation. Biochim. Biophys. Acta 1139, 257-274.
4. White, J. M. (1992) Membrane fusion. Science 258, 917-924.
5. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
6. Rafalski, M., Lear, J. D., and DeGrado, W. F. (1990) Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry 29, 7917-7922.
7. Slepushkin, V. A., Andreev, S. M., Sidorova, M. V., Melikyan, G. B., Grigoriev, V. B., Chumakov, V. M., Grinfeldt, A. E., Manukyan, R. A., and Karamov, E. V. (1992) Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between Meir structure and function. AIDS Res. Hum. Retroviruses 8, 9-18.
8. Martin, I., Defrise-Quertain, F., Decroly, E., Vandenbranden, M., Brasseur, R., and Ruysschaert, J. M. (1993) Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes. Biochim. Biophys. Acta 1145, 124-133.
9. Nieva, J. L., Nir, S., Muga, A., Goni, F. M., and Wilschut, J. (1994) Interaction of the HIV-1 fusion peptide with phospholipid vesicles: Different structural requirements for fusion and leakage. Biochemistry 33, 3201-3209.
10. Kliger, Y., Aharoni, A., Rapaport, D., Jones, P., Blumenthal, R., and Shai, Y. (1997) Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study. J. Biol. Chem. 272, 13496-13505.
11. Blumenthal, R., Schoch, C., Puri, A., and Clague, M. J. (1991) A dissection of steps leading to viral envelope protein-mediated membrane fusion. Ann. N.Y. Acad. Sci. 635, 285-296.
12. Suarez, T., Nir, S., Goni, F. M., Saez-Cirion, A., and Nieva, J. L. (2000) The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: A novel fusogenic sequence. FEBS. Lett. 477, 145-149.
13. Epand, R. M. (2003) Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta 1614, 116-121.
14. Peisajovich, S. G., Epand, R. F., Pritsker, M., Shai, Y., and Epand, R. M. (2000) The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry 39, 1826-1833.
15. Poumbourios, P., Wilson, K. A., Center, R. J., El Ahmar, W., and Kemp, B. E. (1997) Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence. J. Virol. 71, 2041-2049.
16. Weissenhorn, W., Dessen, A., Calder, L. J., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1999) Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16, 3-9.
17. Peisajovich, S. G., and Shai, Y. (2003) Viral fusion proteins: Multiple regions contribute to membrane fusion. Biochim. Biophys. Acta 1614, 122-129.
18. Quintana, F. J., Gerber, D., Kent, S. C., Cohen, I. R., and Shai, Y. (2005) HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J. Clin. Invest. 115, 2149-2158.
19. Freed, E. O., Delwart, E. L., Buchschacher, G. L., Jr., and Panganiban, A. T. (1992) A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. U.S.A. 89, 70-74.
20. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430.
21. Kliger, Y., Peisajovich, S. G., Blumenthal, R., and Shai, Y. (2000) Membrane-induced conformational change during the activation of HIV-1 gp41. J. Mol. Biol. 301, 905-914.
22. Kliger, Y., Gallo, S. A., Peisajovich, S. G., Munoz-Barroso, I., Avkin, S., Blumenthal, R., and Shai, Y. (2001) Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage. J. Biol. Chem. 276, 1391-1397.
23. Bloch, I., Quintana, F. J., Gerber, D., Cohen, T., Cohen, I. R., and Shai, Y. (2007) T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. FASEB J. 21, 393-401.
24. Mobley, P. W., Waring, A. J., Sherman, M. A., and Gordon, L. M. (1999) Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs. Biochim. Biophys. Acta 1418, 1-18.
25. Martin, I., Schaal, H., Scheid, A., and Ruysschaert, J. M. (1996) Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol. 70, 298-304.
26. 13C- enhanced Fourier transform infrared spectroscopy. J. Pept. Res. 55, 330-347.
27. 13C-enhanced Fourier transform infrared spectroscopy. Biochim. Biophys. Acta 1559, 96-120.
28. 13C-enhanced Fourier transform infrared spectroscopy. Protein Sci. 13, 1012-1030.
29. Pereira, F. B., Goni, F. M., Muga, A., and Nieva, J. L. (1997) Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: Dose and sequence effects. Biophys. J. 73, 1977-1986.
30. Curtain, C., Separovic, F., Nielsen, K., Craik, D., Zhong, Y., and Kirkpatrick, A. (1999) The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids. Eur. Biophys. J. 28, 427-436.
31. Yang, J., Gabrys, C. M., and Weliky, D. P. (2001) Solid-state nuclear magnetic resonance evidence for an extended β strand conformation of the membrane-bound HIV-1 fusion peptide. Biochemistry 40, 8126-8137.
32. Yang, R., Yang, J., and Weliky, D. P. (2003) Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides. Biochemistry 42, 3527-3535.
33. Yang, J., and Weliky, D. P. (2003) Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide. Biochemistry 42, 11879-11890.
34. Yang, R., Prorok, M., Castellino, F. J., and Weliky, D. P. (2004) A trimeric HIV-1 fusion peptide construct which does not self-associate in aqueous solution and which has 15-fold higher membrane fusion rate. J. Am. Chem. Soc. 126, 14722-14723.
35. Jaroniec, C. P., Kaufman, J. D., Stahl, S. J., Viard, M., Blumenthal, R., Wingfield, P. T., and Bax, A. (2005) Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain. Biochemistry 44, 16167-16180.
36. Yang, J., Prorok, M., Castellino, F. J., and Weliky, D. P. (2004) Oligomeric β-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophys. J. 87, 1951-1963.
37. 13C FTIR study. J. Mol. Biol. 350, 790-805.
38. Zheng, Z., Yang, R., Bodner, M. L., and Weliky, D. P. (2006) Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy. Biochemistry 45, 12960-12975.
39. Li, Y., and Tamm, L. K. (2007) Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers. Biophys. J. 93, 876-885.
40. Gerber, D., and Shai, Y. (2000) Insertion and organization within membranes of the δ-endotoxin pore-forming domain, helix 4-loop-helix 5, and inhibition of its activity by a mutant helix 4 peptide. J. Biol. Chem. 275, 23602-23607.
41. Gazit, E., Miller, I. R., Biggin, P. C., Sansom, M. S., and Shai, Y. (1996) Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. J. Mol. Biol. 258, 860-870.
42. Surewicz, W. K., Mantsch, H. H., and Chapman, D. (1993) Determination of protein secondary structure by Fourier transform infrared spectroscopy: A critical assessment. Biochemistry 32, 389-394.
43. Jackson, M., and Mantsch, H. H. (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30, 95-120.
44. Wang, X. M., Djordjevic, J. T., Kurosaka, N., Schibeci, S., Lee, L., Williamson, P., and Manolios, N. (2002) T-cell antigen receptor peptides inhibit signal transduction within the membrane bilayer. Clin. Immunol. 105, 199-207.
45. Rajarathnam, K., Hochman, J., Schindler, M., and Ferguson-Miller, S. (1989) Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes. Biochemistry 28, 3168-3176.
46. Rapaport, D., and Shai, Y. (1991) Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J. Biol. Chem. 266, 23769-23775.
47. Serrano, L., Bycroft, M., and Fersht, A. R. (1991) Aromatic-aromatic interactions and protein stability. Investigation by double-mutant cycles. J. Mol. Biol. 218, 465-475.
48. Burley, S. K., and Petsko, G. A. (1985) Aromatic-aromatic interaction: A mechanism of protein structure stabilization. Science 229, 23-28.
49. Sal-Man, N., Gerber, D., Bloch, I., and Shai, Y. (2007) Specificity in transmembrane helix-helix interactions mediated by aromatic residues. J. Biol. Chem. 282, 19753-19761.
50. Aggeli, A., Bell, M., Boden, N., Keen, J. N., Knowles, P. F., McLeish, T. C., Pitkeathly, M., and Radford, S. E. (1997) Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes. Nature 386, 259-262.
51. Center, R. J., Leapman, R. D., Lebowitz, J., Arthur, L. O., Earl, P. L., and Moss, B. (2002) Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76, 7863-7867.
52. de Jong, M. D., Schuurman, R., Lange, J. M., and Boucher, C. A. (1996) Replication of a pre-existing resistant HIV-1 subpopulation in vivo after introduction of a strong selective drug pressure. Antiviral Ther. 1, 33-41.
53. Mayers, D. L. (1997) Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs. Am. J. Med. 102, 70-75.
54. Fleming, K. G., and Engelman, D. M. (2001) Specificity in transmembrane helix-helix interactions can define a hierarchy of stability for sequence variants. Proc. Natl. Acad. Sci. U.S.A. 98, 14340-14344.
55. Senes, A., Ubarretxena-Belandia, I., and Engelman, D. M. (2001) The Cα-H⋯O hydrogen bond: A determinant of stability and specificity in transmembrane helix interactions. Proc. Natl. Acad. Sci. U.S.A. 98, 9056-9061.
56. Manolios, N., Collier, S., Taylor, J., Pollard, J., Harrison, L. C., and Bender, V. (1997) T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat. Med. 3, 84-88.